Grand jury indicts telehealth provider in alleged $100M Adderall distribution scheme
A year and a half after two of its executives were indicted for what prosecutors allege is a $100 million prescription conspiracy, telehealth company Done Global has been accused of healthcare fraud and obstruction as part of the same investigation.
The U.S. Department of Justice announced the charges against the company last week, a day after a grand jury in San Francisco made its decision to formally indict the company for what prosecutors say are incidents of systemic fraud associated with its core business.
Done provides prescriptions for controlled substances over the Internet, particularly Adderall used to treat attention-deficit/hyperactivity disorder (ADHD).
While not illegal in and of itself, the DOJ said the group was submitting erroneous and false claims associated with "reimbursement for Adderall and other stimulants” and attempted to obstruct an investigation into its unlawful activity.
Such obstruction, prosecutors added, included attempting to destroy evidence once it learned of the grand jury hearings.
In announcing the charges against Done, the DOJ said a Florida-based medical practice has also been indicted, accused of aiding in a “scheme to illegally distribute Adderall" that the DOJ said contributed to drug dependency and put patient health at risk.
“As alleged, Done Global used lies and deceit to carry out a sophisticated and wide-ranging telehealth fraud scheme, obtaining over $100 million in the process,” Acting Assistant Attorney General Matthew R. Galeotti of the DOJ’s Criminal Division said in a statement. “From feeding addiction to stealing public funds, rampant healthcare fraud victimizes our citizens and must be stopped. The [DOJ] will not hesitate to hold healthcare companies that defraud Americans accountable for their crimes.”
Central to the complaint is Done’s subscription program. Offered through its telemedicine platform, the program lets patients pay for monthly access to ADHD medications prescribed directly by a provider working with Done.
Prosecutors allege these prescriptions were often doled out without proper medical oversight, with the company using targeted advertising to reach patients seeking drugs in an effort to maximize sales.
As part of the conspiracy, the California-based telehealth group would then submit fraudulent claims to Medicare, Medicaid and commercial insurers, the DOJ stated. These incidents were said to occur from 2020 onward.
By 2023, pharmacies were seeing the red flags for themselves and refused to fill prescriptions associated with Done, which serves patients nationwide. The company responded by attempting to circumvent those pharmacies, prosecutors allege.
The DOJ claims over 40 million tablets of Adderall were prescribed illegitimately and without medical need. The company has previously denied the allegations against the individuals named in this latest indictment.
Awaiting sentencing
Ruthia He, CEO and founder, and David Brody, MD, clinical president of Done, were both arrested in July 2024, facing charges of unlawfully distributing controlled substances and healthcare fraud.
In November 2025—mere weeks before a grand jury indicted the company—the DOJ announced that He and Brody were both convicted of “one count of conspiracy to distribute controlled substances, four counts of distribution of controlled substances, and one count of conspiracy to commit healthcare fraud.”
The duo was accused of overbilling insurance by $14 million and failing to follow medical guidelines when prescribing Adderall. Central to the prosecution’s case was the prescription program. Authorities allege stimulants would be auto-refilled with minimal oversight.
He and Brody are set to be sentenced in February 2026 and face up to 20 years in prison.
Chad is an award-winning writer and editor with over 15 years of experience working in media. He has a decade-long professional background in healthcare, working as a writer and in public relations.